MedTrace Logo

The Effect of Magnesium Citrate Supplementation in Restless Legs Syndrome (RLS)

NCT04462796 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2023-02-17

No results posted yet for this study

Summary

The expected results of this study will have a significant impact on the treatment of RLS/WED patients. Magnesium supplementation (if proven to be beneficial) can be utilized as an inexpensive, safer, biologically plausible alternative to dopamine agonists and α2δ calcium-channel ligands.

Conditions

  • Restless Legs Syndrome

Interventions

DIETARY_SUPPLEMENT

Magnesium Citrate

Magnesium Citrate 200 mg daily

Sponsors & Collaborators

  • OSF Healthcare System

    lead OTHER

Principal Investigators

  • Sasikanth Gorantla, MD · OSF Healthcare Saint Francis Medical Center

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-10
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04462796 on ClinicalTrials.gov